Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Traws Pharma, Inc. - Common Stock (NQ: TRAW )

4.880 -0.110 (-2.20%)
Streaming Delayed Price Updated: 11:18 AM EST, Nov 6, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Traws Pharma, Inc. - Common Stock

Traws Pharma Announces Positive Topline Phase 1 Data for Flu Candidate, Tivoxavir Marboxil
From Traws Pharma, Inc.
Via GlobeNewswire
Traws Pharma Announces Positive Topline Phase 1 Results for COVID Candidate, Ratutrelvir, an Oral Mpro Inhibitor
From Traws Pharma, Inc.
Via GlobeNewswire
Traws Pharma, Inc. Appoints Luba Greenwood to Board of Directors
From Traws Pharma, Inc.
Via GlobeNewswire
Traws Pharma, Inc. Announces Special Shareholders Meeting Results
From Traws Pharma, Inc.
Via GlobeNewswire
Traws Pharma Reports Q2 2024 Financial Results, Provides Recent Business Highlights
From Traws Pharma, Inc.
Via GlobeNewswire
Traws Pharma to Host Corporate Update Call on August 15, 2024, at 8:00 AM ET
From Traws Pharma, Inc.
Via GlobeNewswire
Traws Pharma’s ICAR Poster Highlights Potency of COVID-19 Candidate
Differentiated resistance profile positions Traws’ program as a potential class leader 
From Traws Pharma, Inc.
Via GlobeNewswire
Traws Pharma Reports First Quarter 2024 Financial Results and Provides Business Update
From Traws Pharma, Inc.
Via GlobeNewswire
Traws Pharma Completes First Cohort Dosed in Phase 1 Trial for COVID Therapy
From Traws Pharma, Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.